Center for Cancer Research Patient Travel

CCR的临床研究使命如下：* 进行基于假设的 评估新治疗方法的转化临床试验 * 开发新的 * 开发和提供新技术 用于癌症的分子表征、检测、诊断和监测 * 研究不足的疾病和癌症，发病率增加，预后不良，或涉及 特殊人群 * 开发更好的临床前模型和方法，以加快 癌症的新干预措施。为了实现这些目标，CCR开发并实施了 向所有美国公民开放的临床试验参加临床试验的患者是 在位于马里兰州贝塞斯达的NIH临床中心接受治疗，并报销旅行费用， 住宿和膳食。临床主任患者旅行服务的CCR办公室提供 为所有人提供旅行支助（长途交通、每日津贴[膳食和住宿]） 参与者（包括HIV+参与者）的CCR癌症临床研究方案 （包括HIV相关的恶性肿瘤）和HIV在美国国立卫生研究院在贝塞斯达，马里兰州

The clinical research mission of the CCR is as follows: * Conduct hypothesis-based translational clinical trials that evaluate new therapeutic approaches * Develop novel approaches to early cancer detection and prevention * Develop and deliver novel technologies for molecular characterization, detection, diagnosis, and monitoring of cancer * Emphasize understudied diseases and cancers with increasing incidence, poor prognosis, or involving special populations * Develop better preclinical models and methods to expedite development of novel interventions for cancer. To accomplish these goals CCR develops and carries out clinical trials that are open to all U.S. citizens. Patients enrolled on clinical trials are treated at the NIH Clinical Center in Bethesda, Maryland and are reimbursed for their travel, lodging and meals. The CCR Office of the Clinical Director Patient Travel Service provides support for travel (long-distance transportation, per diem [meals and lodging]) for all participants (including HIV+ participants) on CCR clinical research protocols for cancer (including HIV-associated malignancies) and HIV at the NIH in Bethesda, Maryland